© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Soleno Therapeutics, Inc. (SLNO) stock declined over -1.51%, trading at $48.43 on NASDAQ, down from the previous close of $49.17. The stock opened at $49.03, fluctuating between $48.01 and $50.64 in the recent session.
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing Phase III clinical development program. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.
Employees | 33 |
Beta | -1.44 |
Sales or Revenue | $0.00 |
5Y Sales Change% | 0% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Biotechnology |
Soleno Therapeutics, Inc. (NASDAQ: SLNO) stock price is $48.43 in the last trading session. During the trading session, SLNO stock reached the peak price of $50.64 while $48.01 was the lowest point it dropped to. The percentage change in SLNO stock occurred in the recent session was -1.51% while the dollar amount for the price change in SLNO stock was -$0.74.
The NASDAQ listed SLNO is part of Biotechnology industry that operates in the broader Healthcare sector. Soleno Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Patricia C. Hirano
Vice President of Regulatory Affairs
Mr. James H. MacKaness
Chief Financial Officer
Dr. Anish Bhatnagar M.D.
Pres, Chief Executive Officer, Chief Operating Officer & Director
Ms. Kristen Yen M.S.
Vice President of Clinical Operations
Mr. Anthony Wondka
Senior Vice President & GM
Dr. Neil M. Cowen M.B.A., Ph.D., MBA
Senior Vice President of Drug Devel.
SLNO's closing price is 32.29% higher than its 52-week low of $36.61 where as its distance from 52-week high of $60.92 is -20.5%.
Number of SLNO employees currently stands at 33.
Official Website of SLNO is: https://soleno.life
SLNO could be contacted at phone 650 213 8444 and can also be accessed through its website. SLNO operates from 203 Redwood Shores Parkway, Redwood City, CA 94065, United States.
SLNO stock volume for the day was 292.76K shares. The average number of SLNO shares traded daily for last 3 months was 602.5K.
The market value of SLNO currently stands at $2.09B with its latest stock price at $48.43 and 43.12M of its shares outstanding.